Bioorg. Med. Chem. Lett. 2006, 16, 3419-3423.

Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.

J. Enz. Inh. Med. Chem. 2006, 21, 277-283.

3-(a-Azolylbenzyl)indoles: in vitro and in vivo anti-Leishmania activity and mechanism of action.

Bioorg. Med. Chem. Lett. 2006, 16, 1134-1137.

Synthesis and biologicol evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors.

Tetrahedron Lett. 2006, 47, 6479-6483.

Efficient microwave-assisted synthesis of 2-phenyl-1-(1H-indol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol derivatives with potential antifungal activity.

J. Enz. Inh. Med. Chem. 2006, 21, 313-325.

Synthesis and primary cytotoxicity evaluation of arylmethylenenaphthofuranone derivatives.

SAR and QSAR in Environ. Res. 2006, 17, 299-309.

3D-QSAR COMSIA study on 3-azolylmethylindoles as anti-leishmanial agents.

J. Enz. Inhib. Med. Chem. 2006, 21, 305-312. 

Microtubule target for new antileishmanial drugs refered as ethyl 3-haloacetamidobenzoates.